OLFADOG BIOTECH

Waterloo ·KBO/BCE: BE 0794.892.333

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	09-07-2025	22 d early	2025-00255720
31-12-2023	31-07-2024	14-06-2024	47 d early	2024-00138232

Metric	This company	Sector median	Position in the sector
Solvency	80.0%	53.6%	better than 87% of 42 sector peers
Net result	€-189k	€-16k	better than 34% of 41 sector peers
Equity	€1.44M	€644k	better than 63% of 42 sector peers
Gross operating margin	€-8k	€7k	better than 40% of 33 sector peers
Total assets	€1.80M	€1.71M	better than 51% of 42 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€1.80M
Fixed assets	21/28	€960k
Intangible fixed assets	21	€960k
Current assets	29/58	€843k
Amounts receivable within one year	40/41	€2k
Cash & bank	54/58	€634k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€1.80M
Equity	10/15	€1.44M
Contributions / capital	10/11	€2.04M
Accumulated profits (losses)	14	€-593k
Amounts payable	17/49	€360k
Amounts payable within one year	42/48	€360k
Trade debts payable within one year	44	€360k
Income statement
Gross operating margin	9900	€-8k
Operating result	9901	€-189k
Financial charges	65	€155
Result before taxes	9903	€-189k
Net result for the period	9904	€-189k
Result to be appropriated	9905	€-189k

Summary

Legal nameFR	OLFADOG BIOTECH
AbbreviationFR	OLFADOG